Joanne Curley
Direttore/Membro del Consiglio presso VISTAGEN THERAPEUTICS, INC.
Patrimonio netto: 1 M $ in data 30/04/2024
Provenienza dei contatti di primo grado di Joanne Curley
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 24 | |
| Public Company | Biotechnology | 19 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Joanne Curley tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Cigna Holding Co.
 Cigna Holding Co. Life/Health InsuranceFinance Cigna Holding Co. engages in the provision of medical, dental, disability, life and accident insurance, and related products and services to businesses, governmental and non-governmental organizations, and individuals, through its subsidiaries. The company was founded in 1981 and is headquartered in Bloomfield, CT. | Life/Health Insurance | Public Communications Contact | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Public Communications Contact | |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member Director/Board Member | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| University of California, Los Angeles | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| VistaGen, Inc. | Chairman Chief Executive Officer Chief Executive Officer | ||
| McGill University | College/University | Doctorate Degree Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| VAXCYTE, INC. | Biotechnology | Director/Board Member Chairman | |
Orbus Therapeutics, Inc.
 Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cato BioVentures
 Cato BioVentures Investment ManagersFinance Cato BioVentures (Cato BioVentures) is a venture capital subsidiary of Cato Research LLC founded in 1990 by Allen Cato and Lynda Sutton. The firm is headquartered in Durham, North Carolina. | Investment Managers | Founder Private Equity Investor | |
| Yale University | College/University | Graduate Degree Undergraduate Degree | |
| Haas School of Business | College/University | Undergraduate Degree Masters Business Admin | |
| DMK PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Investor Relations Contact Human Resources Officer | |
MZ Group
 MZ Group Miscellaneous Commercial ServicesCommercial Services Part of @titude Global, MZ Group is a leading investor relations solutions provider. The company is based in New York, NY, and maintains a global footprint with professionals located throughout every time zone and in São Paulo. The company has over 25 years of experience in implementing award-winning investor relations programs and has developed a reputation for delivering tangible, measured results via its robust suite of services. MZ's one-stop-shop platform serves management teams at public and private companies, including SPACs and IPOs. The platform leverages strategic financial communications, industry-leading investment community outreach, public relations, financial media, ESG consulting and software, a market intelligence desk, and technology solutions spanning investor relations websites, conference call/webcasting, video production, and XBRL/EDGAR filing services. The CEO of the company is Rodolfo Zabisky. | Miscellaneous Commercial Services | Investor Relations Contact Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Doctorate Degree | |
| George Washington University | College/University | Graduate Degree Graduate Degree | |
| ECHO THERAPEUTICS, INC. | Medical Specialties | Director/Board Member President | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree | |
Cato Research LLC
 Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chief Executive Officer General Counsel | |
| QUESTCOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Philadelphia College of Pharmacy | College/University | Undergraduate Degree | |
| EXELON CORPORATION | Electric Utilities | Corporate Officer/Principal | |
| Cigna Foundation | President | ||
| Syracuse University | College/University | Undergraduate Degree | |
| ANI PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal | |
Alba Therapeutics Corp.
 Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies | Pharmaceuticals: Major | Corporate Officer/Principal | |
APCO Worldwide LLC
 APCO Worldwide LLC Miscellaneous Commercial ServicesCommercial Services APCO Worldwide LLC engages in the provision of advisory and advocacy communications consultancy solutions. It offers communications, public affairs, government relations, legal, risk, organizational transformation, international relations, corporate responsibility, and brand marketing services. The company was founded by Margery Kraus in 1984 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Orionis Biosciences, Inc.
 Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | Packaged Software | Chief Tech/Sci/R&D Officer | |
| University of San Diego School of Law | College/University | Graduate Degree | |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Chief Executive Officer | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The Seminar
 The Seminar Internet Software/ServicesTechnology Services The Seminar operates an online annual forum for senior communications and public affairs executives. | Internet Software/Services | Corporate Officer/Principal | |
| Coastal Carolina University | College/University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 45 |
| Canada | 4 |
| Germania | 2 |
Settori
| Health Technology | 21 |
| Consumer Services | 16 |
| Commercial Services | 6 |
| Technology Services | 4 |
| Finance | 3 |
Posizioni
| Director/Board Member | 173 |
| Corporate Officer/Principal | 95 |
| Independent Dir/Board Member | 40 |
| Undergraduate Degree | 34 |
| President | 24 |
Contatti più connessi
| Insiders | |
|---|---|
| Jon Saxe | 43 |
| Patrick Enright | 41 |
| Brian Underdown | 34 |
| Kurt von Emster | 34 |
| Maha Katabi | 28 |
| Shawn Singh | 22 |
| Brian Kotzin | 20 |
| Maggie FitzPatrick | 16 |
| Scott Morrison | 16 |
| Jerry Gin | 13 |
| H. Ralph Snodgrass | 11 |
| Reid Adler | 10 |
| Allen Cato | 9 |
| Jonathan R. Wolter | 9 |
| Michael Morrissey | 8 |
- Borsa valori
- Insiders
- Joanne Curley
- Connessioni Società
